| Primary |
| Depression |
66.7% |
| Sleep Disorder |
33.3% |
|
| Atrial Fibrillation |
25.0% |
| Insomnia |
25.0% |
| Swollen Tongue |
25.0% |
| Thinking Abnormal |
25.0% |
|
| Secondary |
| Maternal Exposure Before Pregnancy |
34.3% |
| Product Used For Unknown Indication |
21.7% |
| Depression |
8.4% |
| Foetal Exposure During Pregnancy |
7.7% |
| Schizoaffective Disorder |
6.3% |
| Bipolar I Disorder |
3.1% |
| Drug Use For Unknown Indication |
2.8% |
| Essential Hypertension |
2.4% |
| Insomnia |
2.1% |
| Pain |
2.1% |
| Maternal Drugs Affecting Foetus |
1.4% |
| Urinary Tract Infection |
1.4% |
| Enterobacter Infection |
1.0% |
| Major Depression |
1.0% |
| Cervicobrachial Syndrome |
0.7% |
| Epilepsy |
0.7% |
| Hypertension |
0.7% |
| Intervertebral Disc Disorder |
0.7% |
| Irritable Bowel Syndrome |
0.7% |
| Malaria Prophylaxis |
0.7% |
|
| Epilepsy |
11.5% |
| Pierre Robin Syndrome |
11.5% |
| Toxicity To Various Agents |
9.6% |
| Maternal Exposure Before Pregnancy |
7.7% |
| Respiratory Disorder |
7.7% |
| Overdose |
5.8% |
| Delirium |
3.8% |
| Diarrhoea |
3.8% |
| Drug Toxicity |
3.8% |
| Maternal Drugs Affecting Foetus |
3.8% |
| Orthostatic Hypotension |
3.8% |
| Rhabdomyolysis |
3.8% |
| Tremor |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Vertigo |
3.8% |
| Abdominal Pain |
1.9% |
| Acute Prerenal Failure |
1.9% |
| Atrioventricular Block |
1.9% |
| Confusional State |
1.9% |
|
| Concomitant |
| Depression |
22.8% |
| Pain |
12.4% |
| Drug Use For Unknown Indication |
11.6% |
| Product Used For Unknown Indication |
8.0% |
| Sleep Disorder |
4.4% |
| Major Depression |
4.0% |
| Hepatitis C |
3.6% |
| Anaesthesia |
3.2% |
| Personality Disorder |
3.2% |
| Antiallergic Therapy |
2.8% |
| Bipolar Disorder |
2.4% |
| Blood Follicle Stimulating Hormone Decreased |
2.4% |
| Blood Luteinising Hormone Decreased |
2.4% |
| Dermatitis Contact |
2.4% |
| Eczema |
2.4% |
| Hypertension |
2.4% |
| Hypogonadism |
2.4% |
| Hypopituitarism |
2.4% |
| Multiple Sclerosis |
2.4% |
| Vitamin D Deficiency |
2.4% |
|
| Ventricular Extrasystoles |
17.6% |
| Death |
8.8% |
| Weight Increased |
7.4% |
| Gamma-glutamyltransferase Increased |
5.9% |
| Suicidal Ideation |
5.9% |
| Hyponatraemia |
4.4% |
| Hyposmia |
4.4% |
| Nausea |
4.4% |
| Rhabdomyolysis |
4.4% |
| Sleep Disorder |
4.4% |
| Tremor |
4.4% |
| Vomiting |
4.4% |
| Anaphylactic Shock |
2.9% |
| Depression |
2.9% |
| Drug Interaction |
2.9% |
| Dysaesthesia |
2.9% |
| Fall |
2.9% |
| Heart Rate Increased |
2.9% |
| Melanocytic Naevus |
2.9% |
| Mental Impairment |
2.9% |
|
| Interacting |
| Depression |
53.8% |
| Pain |
19.2% |
| Product Used For Unknown Indication |
7.7% |
| Anxiety |
3.8% |
| Insomnia |
3.8% |
| Migraine |
3.8% |
| Rheumatoid Arthritis |
3.8% |
| Smoking Cessation Therapy |
3.8% |
|
| Serotonin Syndrome |
28.6% |
| Tremor |
28.6% |
| Drug Interaction |
7.1% |
| Drug Withdrawal Syndrome Neonatal |
7.1% |
| Grand Mal Convulsion |
7.1% |
| Intentional Overdose |
7.1% |
| Unevaluable Event |
7.1% |
| Vertigo |
7.1% |
|
